5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Iantrek, Inc.
- Study ID
- NCT07480343
- Status
- Enrolling By Invitation
Conditions
- Open-angle Glaucoma (OAG)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CycloPen Micro-Interventional Cyclodialysis System — PROCEDUREThe CycloPen Micro-Interventional Cyclodialysis System is used to create and cyclodialysis cleft and deliver allograft scleral tissue and/or viscous material to reinforce and maintain the cleft postoperatively.
- CycloPen Micro-Interventional Cyclodialysis System Post Cataract — PROCEDUREAfter cataract surgery, the CycloPen Micro-Interventional Cyclodialysis System is used to create and cyclodialysis cleft and deliver allograft scleral tissue and/or viscous material to reinforce and maintain the cleft postoperatively.
Study Details
This study is designed to collect clinical data at 3, 4, and 5 years postoperatively for participants who completed the CREST Study without having secondary IOP-lowering surgery in the study eye(s).
Key Dates
- Start date
- Sep 15, 2025
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 250 participants (estimated)
Arms
- Arm: Bio-reinforced Cyclodialysis in conjunction with cataract surgeryCataract surgery is performed, then followed by bio-reinforced cyclodialysis using the CycloPen Cyclodialysis System
- Arm: Bio-reinforced Cyclodialysis aloneBio-reinforced cyclodialysis is performed using the CycloPen Cyclodialysis System
Primary Outcome Measure
Mean change in intraocular pressure (IOP) [ Time Frame: From before bio-interventional cyclodialysis to 60 months after surgery ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CREST-XT Site 05 | Newport Beach | California | 92663 | - |
| CREST-XT Site 03 | Cape Coral | Florida | 33904 | - |
| CREST-XT Site 07 | Atlanta | Georgia | 30342 | - |
| CREST-XT Site 12 | Chevy Chase | Maryland | 20815 | - |
| CREST-XT Site 13 | Rockville | Maryland | 20852 | - |
| CREST-XT Site 16 | Las Vegas | Nevada | 89145 | - |
| CREST-XT Site 15 | New York | New York | 10034 | - |
| CREST-XT Site 01 | Fort Washington | Pennsylvania | 19034 | - |
| CREST-XT Site 04 | Crossville | Tennessee | 38555 | - |
| CREST-XT Site 11 | Salt Lake City | Utah | 84132 | - |
Find similar trials in Newport Beach, CA
Related Studies
- Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel DilationPHASE2 · Recruiting · Qlaris Bio, Inc. · Palo Alto, California
- Direct vs Standard SLT for Glaucoma: A Noninferiority TrialRecruiting · Medical University of South Carolina · Charleston, South Carolina